நிக்கோல் ந்யாபலீ News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from நிக்கோல் ந்யாபலீ. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In நிக்கோல் ந்யாபலீ Today - Breaking & Trending Today

No improvement in outcomes with rapid, high-sensitivity troponin T testing protocol at one year


 E-Mail
Using more sensitive and frequent repeat testing of a blood test that indicates heart injury to guide the treatment of low-risk patients with symptoms of a possible heart attack resulted in patients being discharged earlier and receiving fewer cardiac stress tests but did not improve patient outcomes after one year, according to research presented at the American College of Cardiology s 70th Annual Scientific Session. In fact, a subset of patients receiving this more sensitive and frequent blood testing protocol were more likely to have a heart attack or to die during the one-year follow-up period compared with patients whose treatment was informed by the results of conventional blood testing procedures. ....

Flinders University , South Australia , Nicole Napoli , Yann Nguyen , Research Council Of Australia , National Health , American College Of Cardiology , American College , Annual Scientific , Derek Chew , Medical Research Council , Randomized Clinical Trial , Medicine Health , Clinical Trials , Critical Care Emergency Medicine , Death Dying , ஃப்லிஂடர்‌ஸ் பல்கலைக்கழகம் , தெற்கு ஆஸ்திரேலியா , நிக்கோல் ந்யாபலீ , ஆண்டு ஂக்யந் , ஆராய்ச்சி சபை ஆஃப் ஆஸ்திரேலியா , தேசிய ஆரோக்கியம் , அமெரிக்கன் கல்லூரி ஆஃப் இருதயவியல் , அமெரிக்கன் கல்லூரி , ஆண்டு அறிவியல் , டெரெக் மெல் ,

Clopidogrel superior to aspirin for long-term post-stent maintenance


 E-Mail
Clopidogrel outperformed aspirin in what is believed to be the first and largest randomized trial to compare the effectiveness of the two antiplatelet drugs as long-term maintenance therapy for patients who had no adverse events after one year of dual antiplatelet therapy (DAPT) following the insertion of a coronary stent. After two years of follow-up, chronic maintenance therapy with clopidogrel resulted in a 30% reduction in deaths, heart attacks, strokes or major bleeding events, according to research presented at the American College of Cardiology s 70th Annual Scientific Session.
These data confirm our working hypothesis that long-term maintenance antiplatelet monotherapy with clopidogrel produces better outcomes than aspirin in patients who are adverse event-free at one year after coronary stenting, said Hyo-Soo Kim, MD, PhD, professor of internal medicine at Seoul National University Hospital in South Korea and lead author of the study. ....

Soult Ukpyolsi , South Korea , Hyo Soo Kim , Nicole Napoli , Yann Nguyen , Antiplatelet Monotherapy , Seoul National University Hospital , American College Of Cardiology , Korean Ministry Of Health , American College , Annual Scientific , South Korean Ministry , Host Exam Randomized Controlled Trial , தெற்கு கொரியா , ஹயோ சூ கிம் , நிக்கோல் ந்யாபலீ , ஆண்டு ஂக்யந் , சியோல் தேசிய பல்கலைக்கழகம் மருத்துவமனை , அமெரிக்கன் கல்லூரி ஆஃப் இருதயவியல் , கொரியன் அமைச்சகம் ஆஃப் ஆரோக்கியம் , அமெரிக்கன் கல்லூரி , ஆண்டு அறிவியல் , தெற்கு கொரியன் அமைச்சகம் ,